Ritonavir Completed Phase 4 Trials for Glucose Metabolism Disorders / Human Immunodeficiency Virus (HIV) Infections / Lipodystrophies / Dyslipidemia / Cardiovascular Disease (CVD) / Metabolic Diseases Basic Science

Indications	Status	Purpose	Phase
DBCOND0030843 (Glucose Metabolism Disorders) DBCOND0035016 (Human Immunodeficiency Virus (HIV) Infections) DBCOND0026618 (Lipodystrophies) DBCOND0020718 (Dyslipidemia) DBCOND0057913 (Cardiovascular Disease (CVD)) DBCOND0030621 (Metabolic Diseases)	Completed	Basic Science	4

clinicaltrials.gov Identifier	Title	Drugs
NCT00192621	Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects	Lamivudine (DB00709) Lopinavir (DB01601) Ritonavir (DB00503) Zidovudine (DB00495)